A 6-year-old girl with B-cell‚ñÅlymphoblastic lymphoma in the maintenance phase of treatment was admitted to the hospital with fever and neutrophilia according to the usual diagnostic procedure.
Her past medical history was relevant for symptomatic relatives in the same household who had tested positive for SARS-CoV-2.
The patient had a day of coughing evolution, but otherwise she was asymptomatic at admission, had fever and did not report symptoms of cough, dyspnea, fatigue, abdominal pain or diarrhea.
It was positive in a test for SARS-CoV-2 by PCR from nasopharyngeal swabs.
Infectious disease specialists were consulted and an initial chest X-ray and monitoring of inflammation markers were recommended.
The DHF, lactate dehydrogenase and interleukin-6 were not high and decreased during hospitalization.
Ferritin was slightly elevated at 1098 ng/mL and dropped to 983 ng/mL in a second test.
Her chest X-ray was normal and her clinical status was stable; no further X-ray was performed before discharge.
Your oral chemotherapy was continued while you were neutrocytopenic, according to the Children's Oncology Group AALL1131 guidelines and while you were infected with the virus.
The patient was discharged after 10 days of hospitalization.
A new test of SARS-CoV-2 was performed from nasopharyngeal swabs by PCR three weeks after diagnosis and yielded negative results.
Serological tests for IgG from SARS-CoV-2 six weeks after diagnosis were positive, showing that the patient had elicited an immune response while he was immunocompromised.
